Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments

Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments

Abstract Background Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKn...

Full description

Bibliographic Details
Main Authors: P.-H. Mackeprang, D. Vuong, W. Volken, D. Henzen, D. Schmidhalter, M. Malthaner, S. Mueller, D. Frei, W. Kilby, D. M. Aebersold, M. K. Fix, P. Manser
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Radiation Oncology
Subjects:
CyberKnife
Monte Carlo
Benchmarking
Dose calculation
TPS
QA
Online Access:http://link.springer.com/article/10.1186/s13014-019-1370-5

Internet

http://link.springer.com/article/10.1186/s13014-019-1370-5

Similar Items